thalidomide has been researched along with Cytomegalic Inclusion Disease in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Groves, IJ | 1 |
| Jackson, SE | 1 |
| Poole, EL | 1 |
| Nachshon, A | 1 |
| Rozman, B | 1 |
| Schwartz, M | 1 |
| Prinjha, RK | 1 |
| Tough, DF | 1 |
| Sinclair, JH | 1 |
| Wills, MR | 1 |
| Kim, JH | 1 |
| Goulston, C | 1 |
| Sanders, S | 1 |
| Lampas, M | 1 |
| Zangari, M | 1 |
| Tricot, G | 1 |
| Hanson, KE | 1 |
| Haslett, PA | 1 |
| Hanekom, WA | 1 |
| Muller, G | 1 |
| Kaplan, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacologic T Cell Costimulation In HIV Disease[NCT00053430] | Phase 2 | 40 participants (Actual) | Interventional | 2001-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for thalidomide and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
Topics: Azepines; Bacterial Proteins; Benzodiazepines; Cell Cycle Proteins; Cyclin T; Cyclin-Dependent Kinas | 2021 |
Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.
Topics: Aged; Antiviral Agents; Boronic Acids; Bortezomib; Cytomegalovirus; Cytomegalovirus Infections; Fema | 2012 |
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro.
Topics: Adjuvants, Immunologic; CD8-Positive T-Lymphocytes; Cell Division; Coculture Techniques; Cytokines; | 2003 |